Clinical Trial: Single-center, single-arm exploratory trial of Deucravacitinib in the treatment of refractory localized scleroderma (China)

China, Aug. 14 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Single-center, single-arm exploratory trial of Deucravacitinib in the treatment of refractory localized scleroderma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130056

Registration Time: 2026/08/13

Type: Interventional study

Primary Sponsor: Dematology Hospital of Southern Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336845

Published by HT Digital Content Services with permission from Health Daily Digest....